The National Strategic Plan (NSP) 2017 – 2025 is the plan produced by the government of India (GoI) which sets out what the government believes is needed to eliminate TB in India. The NSP 2017 – 2025 describes the activities and interventions that the GoI believes will bring about significant change in the incidence, prevalence and mortality from TB. This is in addition to what is already going on in the country.
The NSP sets out the recommendations of the GoI. However, the rate at which these recommendations are implemented, will largely depend on the action taken by individual states.
The Vision is of a TB free India with zero deaths, disease and poverty due to tuberculosis
The Goal is to achieve a rapid decline in the burden of TB, mortality and morbidity, while working towards the elimination of TB in India by 2025.
The requirements for moving towards TB elimination in India have been arranged in four strategic areas of Detect, Treat, Prevent & Build. There is also across all four areas, an overarching theme of the Private Sector. Another overarching theme, is that of Key Populations.
Another “thrust” area is that of the Programmatic Management of Drug Resistant TB (PMDT).
The aim is to detect all those people with drug sensitive TB as well as those with drug resistant TB. The emphasis is to be on reaching TB patients seeking care from private providers and also finding people with undiagnosed TB in “high risk” or key populations. This is to be done through:
The Technical & Operational Guidelines for TB Control (TOG) describes how various tests should be used to diagnose anyone who has signs and symptoms suggesting that they might have TB. The tests to be used are sputum smear microscopy, chest X ray and the new CB-NAAT test. The CB-NAAT test is beginning to be made available throughout India. There is a diagram, or set of rules, which shows which tests should be used for different groups of people.
There is a further explanation on the page on Testing & diagnosis of TB in India.
The main objective of active case finding (ACF) is to detect TB cases early and to initiate treatment promptly. The NSP emphasizes the need to shift from passive case finding, which is waiting for people to seek care, to ACF which involves seeking out people in targeted groups.
Initiate and sustain all patients on appropriate anti-tb treatment wherever they seek care. Provide patient friendly systems and social support. This is to be done through:
At present TB drugs are free at government centres. The NSP plan is that eventually TB drugs will be available free from private centre pharmacies as well. Currently it is believed that only half of all TB patients make use of the free medicines. It is believed that making the TB drugs available in private hospitals:
“will also help remove the stigma among that section of society which is hesitant to approach government run centres for taking medicines”Jagdish Prasad, Director General of Health Services
It has now been announced that patients with TB will receive R500 ($8) a month for food.
Under nutrition is a risk factor for TB in India. Under nutrition worsens the nutritional status, generating a vicious cycle which can lead to adverse outcomes during and after treatment for patients with active TB. This includes those with MDR-TB. So this payment is partially to ensure that patients with TB have adequate food. There is more about food and TB.
“We need to understand when this scheme will be rolled out, how will the money be dispensed and if it includes all TB patients, including those seeking care in the private sector”. 1“A side effect of tuberculosis in India: crippling debt”, https://www.reuters.com/article/us-india-health/a-side-effect-of-tuberculosis-in-india-crippling-debt-idUSKCN1G407M, Feb 20, 2018, Chapal Mehra, Survivors Against TB
It affects mainly poor and malnourished people, Finance Minister Arun Jaitley told parliament in his Feb 1 budget speech, a rare official acknowledgement of the scale and impact of the disease. In the 2018 budget Rs 600 crore was allocated for nutritional support for TB patients.
Preventing the emergence of TB in susceptible populations. This is to be done through
Build and strengthen relevant policies. Provide extra capacity for institutions and extra human resources capacity. This is to be done through:
At least half of those treated for TB in India first attend the largely unorganized and unregulated private sector. Patients from low income households will often lose several months of their income in the process of paying for inappropriate diagnostics and treatments before starting approved therapy.
Patients treated by private providers are not usually notified to the RNTCP, despite government orders to that effect. Patients cared for by private providers rarely receive sputum testing, and DST. Similarly, public health services such as surveillance, adherence monitoring, contact investigation, and outcome recording rarely reach privately treated patients.
There is now to be a major change in the way that the RNTCP engages with private providers. Partnership is to be the way forward. The previous approach was for private providers to direct people to the RNTCP to receive their care in the public sector. Now the approach is to be for the public sector RNTCP to work with the private sector, assisting the private sector to provide high quality care.
The new strategy for reaching patients in the private sector amounts to a total change in the way that the RNTCP has engaged private providers before. The new strategy is going to be systematic and large scale, rather than ad hoc and insignificant. Rather than the public sector competing with private providers the RNTCP will work with them to deliver quality STCI services to the entire population.
The aim is for the annual number of TB cases notified by private providers to increase ten fold, from 0.2 to 2 million annually. That is private providers should be providing 56% of total case notifications by 2020. For the first time there will also be a budget appropriate to both the size of the problem and the opportunity of private sector care.
The approach will be to firstly capture all TB patients by attracting notification from private providers and then work to improve the quality of care. Private providers will be provided with incentives.
Private providers will be provided with incentives (i.e. money) to encourage TB case notification, to ensure treatment adherence and also treatment completion. The money will be provided upon notification to the TB reporting software Nikshay. A direct beneficiary transfer (DBT) system will be used so that the money goes directly to the providers bank account.
The money for the Private Sector TB Care Provider is as follows:
Rs 500/- on completion of the entire course of TB treatment.
For notification and management of a drug sensitive patient over 6-9 months as per STCI, a private provider will be eligible to receive Rs 2750/-. For notification and correct management of a drug resistant case over 24 months as per STCI, a private provider will be eligible to receive Rs 6750/-.
Benefits given to TB patients in the public sector will be extended to patients in the private sector including social welfare support. Notification and adherence will be linked to integrated patient notification and social welfare payments. A system is to be put in place to provide money to patients for validated services via Aashar-enabled Direct Benefit Transfer (DBT).
Key populations are generally regarded as people who are socially vulnerable and people who are clinically high risk. They face barriers in accessing care. ACF in vulnerable groups is to be a focus of the NSP over the next five years. Some of the priority groups are as follows:
|Priority||Urban area||Rural area||Tribal area|
|1||Slum||Difficult to reach villages||Difficult to reach villages and hamlets|
|2||Prison inmates||Mine workers||Villages with known higher case load|
|3||Old Age homes||Stone crusher workers||Tribal school hostels|
|4||Construction site workers||Population groups with known high malnutrition||Areas with known high malnutrition|
|5||Refugee camps||Populations known to drink raw milk||Villages seeking care from traditional healers|
|6||Night shelters||Populations known to eat uncooked meat||Populations known to drink raw milk|
The cost of the NSP is going to depend on the pace of implementation of the strategy, the demand from states, and the availability of resources. It is expected that the cost of implementing the new NSP will be Rs 16,649 (USD 2,485 million). This would be a significant increase over the budget for the NSP 2012-2017.
A national level annual review of the NSP will be undertaken. There are also some main NSP impact indicators, & some main outcome indicators as well as some results indicators for PMDT.
|1||Total TB patient notifications||1.74 mil||3.6 mil||2.7 mil||2 mil|
|2||Total patient notifications from private providers||0.19 mil||2 mil||1.5 mil||1.2 mil|
|3||No. of MDR/RR patients notified||28,096||92,000||69,000||55,000|
|4||Proportion of notified TB patients offered DST||25%||80%||98%||100%|
|5||Proportion of notified patients initiated on treatment||90%||95%||95%||95%|
|6||Treatment success rate among notified DSTB||75%||90%||92%||92%|
|7||Treatment success rate among notified DRTB||46%||65%||73%||75%|
|8||Proportion of identified targeted key affected population undergoing active case finding||0%||100%||100%||100%|
|9||Proportion of notified TB patients receiving financial support through DBT||0%||80%||90%||90%|
|Proportion of notified patients offered DST||25%||50%||60%||80%||100%|
|No. of presumptive DRTB patients to be examined||341,395||600,000||700,000||1,100,000||1,500,000|
|No. of MDR/RR patients notified||29,057||53,460||66,000||92,000||55,000|
|No. of MDR/RR patients initiated on treatment||27,104||48,114||59,400||82,800||49,500|
|No. of XDR TB patients notified||2,340||2,406||2,970||4,140||2,475|
|No. of XDR TB patients initiated on treatment||2,127||2,165||2,673||3,726||2,228|
|Treatment success rate for MDR/RR TB||46%||48%||48%||65%||75%|
There are some more TB statistics for India.
Would you like to send us a comment about this page?
(These are PDFs which may be slow to load & not all may be directly referred to on this page)
Guidelines on Programmatic Management of Drug-resistant Tuberculosis in India (PMDT) PMDT
Guidelines on Programmatic Management of Drug-resistant Tuberculosis in India Annexes (PMDT) PMDTAnnexures
RNTCP National Strategic Plan 2012 – 2017 NSP-2012-2017
RNTCP National Strategic Plan 2017 – 2025 NSP Draft 2017-2025
Standards for TB Care in India Standards TB Care India
TB India 2017 Revised National TB Control Programme Annual Status Report, New Delhi, 2017 TB India 2017
Technical and Operational Guidelines for Tuberculosis Control in India 2016 Part 1 TOG-Part-1
Technical and Operational Guidelines for Tuberculosis Control in India 2016 Part 2 TOG-Part-2
[ + ]
|1.||↑||“A side effect of tuberculosis in India: crippling debt”, https://www.reuters.com/article/us-india-health/a-side-effect-of-tuberculosis-in-india-crippling-debt-idUSKCN1G407M, Feb 20, 2018, Chapal Mehra, Survivors Against TB|
|2.||↑||“To eradicate TB, many doctors must first learn how to diagnose it”, 2018, New Indian Express, www.newindianexpress.com/thesundaystandard/2018/|